Sculptor Capital LP Geron Corp Put Options Transaction History

Sculptor Capital LP

  • $3.41 Billion
  • Q4 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2018

Nov 13, 2018
BUY
$1.76 - $6.38 $393,712 - $1.43 Million
223,700 Added 207.13%
331,700 $584,000
Q2 2018

Aug 13, 2018
SELL
$3.29 - $4.82 $380,324 - $557,192
-115,600 Reduced 51.7%
108,000 $370,000
Q1 2018

May 14, 2018
BUY
$1.81 - $5.98 $404,716 - $1.34 Million
223,600 New
223,600 $0

Others Institutions Holding GERN

# of Institutions
306
Shares Held
465M
Call Options Held
1.07M
Put Options Held
648K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $895M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email